Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3759

Bone Grafts and Substitutes Market by Product (Allografts, Bone Grafts Substitutes, and Cell-based Matrices), by Application (Spinal Fusion, Long Bone, Foot & Ankle, Craniomaxillofacial, Joint Reconstruction, and Dental Bone Grafting) - Global Opportunity Analysis and Industry Forecast, 2014-2022

LI 161774
Pages: 130
Nov 2016 | 3334 Views
face gplus_n
Author's : Deepa Tatkare
Tables: 47
Charts: 62
twit_n pr_n

Bone Grafts and Substitutes Market Overview:

Global Bone Grafts and Substitutes Market was valued at $2,443 million in 2015, and is expected to reach $3,397 million by 2022, registering a CAGR of 4.1% during the forecast period 20162022. Bone grafts are implantable materials that promote bone healing, bone formation, and osseous reconstruction due to its osteoconductive, osteogenic, and osteoinductive properties. Bone grafting is a surgical procedure for replacing a missing or defected bone with a material (bone graft) from a patient’s own body, cadaver, animals, or a different person. Bone grafts are used in sports, trauma plastic, facial, and spinal surgery. Bone grafting finds its application in wound healing and complex fracture treatment, among others. Bone grafts can also be used to fill voids in case of absence of bones or help in provision of structural stability.

Increase in in incidence of bone & joint disorders, technological advancements in medical field, development of biocompatible synthetic bone grafts, increase in demand for dental bone grafts drive the market grwoth. However, high cost of surgeries and ethical issues related to bone grafting procedures hamper the market growth. Conversely, increase in focus of key players towards R&D activities in bone grafts and its substitutes and upsurge in demand for orthopedic procedures among geriatric population are expected to provide lucrative opportunities for the market players in the future.

Segment Review

According to AMR analysis, bone graft substitutes segment accounted for more than half of the overall market in 2015, and is expected to dominate the market during the forecast period. This is attributed to the increase in prevalence of bone and joint disorders. In addition, these bone graft substitutes are used in varied applications such as bone replacement, posttraumatic skeletal conditions, and other bone-related problems. Moreover, advancements in bone graft materials and development of innovative products have fueled the market growth.

LAMEA Bone Grafts and Substitutes Market

Increase in incidence of orthopedic disorders coupled with rapid growth in geriatric population drives the growth of the BGS market in the LAMEA region. However, the countries in Latin America have low gross income, therefore do not spend on the development of new methods and devices for the diagnosis and treatment of orthopedic disorders. Lack of healthcare facilities and increased need for treatment devices for orthopedic disorders have increased the penetration of major players in the Middle East region. Nevertheless, the market growth is driven by improving healthcare infrastructure coupled with rise in disposable income.

Increasing Incidence of Musculoskeletal Conditions

Increase in incidence of musculoskeletal conditions has increased the usage of bone grafts and their substitutes in the market. Bone graft is an ideal mode of treatment for complex skeletal defects. Musculoskeletal conditions include a variety of disorders that affect muscles, bones, and joints. Arthritis, low back pain, fibromyalgia, and gout tendinitis are the different forms of musculoskeletal disorders. The risks associated with musculoskeletal conditions increase with age, lack of physical activity, and obesity. Musculoskeletal diseases affect the adult population. According to National Health Interview Survey, in 2012, around 126 million adults were affected by this disease in the U.S. According to Labor Force Survey (LFS), about 553,000 cases were registered for all work-related musculoskeletal disorder out of the total of 1,243,000 cases.

Technological Advancements in Medical Devices Leading to Shift from Autograft to Allograft Procedures

Over the past few years, bone grafts and substitutes industry size has witnessed remarkable growth due to technological advancements in the medical field. Technological advancements in this sector have increased the array of grafting materials, including xenograft, allograft, and synthetic materials. Synthetic grafts products and expensive demineralized bone matrix are alternatives to autografts.

Development of Biocompatible Synthetic Bone Grafts

Increase in demand for biocompatible grafts has increased the interest and efforts of companies to develop comprehensive orthobiologic platforms. Biocompatible bone grafts do not face the issue of rejection from host, hence, the development of biocompatible synthetic bone grafts is one of the major trends observed in the market. The development of biocompatible bone graft materials has reduced such failures and enhanced normal bone formation rate in hosts. The market has witnessed the development of many biocompatible bone grafts and their substitutes (such as B-OstIN and hydroxyapatite allografts). As per Basic Healthcare Products, B-OstIN has been implanted with minimum 12 months of follow-up in 500 patients, and has shown no adverse effects. Thus, the development of biocompatible bone grafts has provided an ideal substitute to autogenous bone grafts.

Obesity and Diabetes to Increase the Risk of Degenerative Joint Diseases

Increase in prevalence of obesity and diabetes is set to drive the demand for bone grafts and bone substitutes, worldwide. Aliments, such as diabetes and obesity, increase the risk of degenerative joint disease manifold. According to the Report Global Burden of Disease, WHO, it is estimated that about 285 million people suffered from diabetes in 2010, and this is estimated to increase to 438 million by 2030. People with diabetes are prone to suffer from osteoporosis and joint disorders. Similarly, a person with obesity faces 60% more chances of developing arthritis and other joint disorders.

High Cost of Surgeries

Bone grafting, spinal fusion, and joints reconstruction incur high cost. For instance, as per ECRI Institute, more than $19 billion is spent on bone grafts and implant bone graft supplies. Moreover, a simple grafting procedure using bone from cadavers or cow costs about $200$1,200 for a single implant area. Thus, the high cost of surgeries is expected to hamper the market growth.

Ethical Issues Related with Bone Grafting Procedures

Bone grafting involves the use of allografts and xenografts, which are transplanted from another donor of same or different species, and are obtained from human and animal cadavers. The refusal rate of allograft grating procedures among patients is high due to ethical issues. For instance, a study conducted by BMC Medical Ethics states that out of the sample of 100 patients, about 20% of the patients refuse to accept allografts for their grafting surgery. The reason for this was specific religious affiliations. For instance, Hinduism does not support the use of allografts from cow and pigs. Moreover, certain patients do not accept allografts from human remains.

The major players operating in this market include Medtronic plc, Stryker Corporation, DePuy Synthes, Integra Lifesciences Holdings Corporation, Wright Medical Group N.V., Zimmer Biomet Holdings, Inc., Xtant Medical Holdings, Inc. (Bacterin), Arthrex, Inc., Baxter International Inc., and Musculoskeletal Transplant Foundation (MTF). The other players (profiles not included in the report) in the value chain include NovaBone Products, LLC, BonAlive Biomaterials Ltd., Sigma Graft Biomaterials, Pioneer Surgical Technology Inc., RTI Biologics, Inc., Orthofix International N.V., Citagenix Inc., Heraeus Medical GmbH, Graftys SA, and NuVasive, Inc.

Key Benefits

  • The report provides an in-depth analysis of the market along with current bone grafts and substitutes market trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis for the period of 20142022 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product helps in understanding the type of devices used to treat musculoskeletal disorders and degenerative joints diseases.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • Comprehensive analysis of the geographical regions helps to determine the prevailing opportunities in these regions.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the global market.
  • Extensive analysis of the market share is conducted by following key product positioning and by monitoring the top contenders within the market framework.

Bone Grafts Substitutes Market Key Segments:

By Product

  • Allografts
    • Machined Allografts
    • Demineralized Bone Matrix
  • Bone Grafts Substitutes
    • Bone Morphogenic Proteins (BMP)
    • Synthetic Bone Grafts
  • Cell-based Matrices

By Application

  • Spinal Fusion
  • Trauma
  • Craniomaxillofacial
  • Joint Reconstruction
  • Dental Bone Grafting

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Israel
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXperspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Market share analysis, 2015
3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 Increasing incidences of musculoskeletal conditions
3.4.1.2 Technological advancements in medical devices leading ta shift from autograft tallograft
3.4.1.3 Development of biocompatible synthetic bone grafts
3.4.1.4 Obesity and diabetes tincrease the risk of denegenerative joint diseases

3.4.2 Restraints

3.4.2.1 High cost of surgeries
3.4.2.2 Ethical issues related with bone grafting procedures

3.4.3 Opportunities

3.4.3.1 Emerging markets toffer lucrative growth opportunities

3.5 Government Regulations

3.5.1 FDA
3.5.2 Health Canada
3.5.3 CE Mark
3.5.4 Ministry of Health, Labor and Welfare (MHLW)
3.5.5 Therapeutic Goods Administration (TGA)

3.6 Reimbursement Scenario

3.6.1 U.S.
3.6.2 Europe
3.6.3 Asia-Pacific
3.6.4 LAMEA

Chapter: 4 WORLD BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ALLOGRAFTS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Demineralized Bone Matrix (DBM)

4.2.4.1. Market size and forecast

4.2.5. Machined Allografts

4.2.5.1. Market size and forecast

4.3. BONE GRAFT SUBSTITUTES

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Bone Morphogenic Proteins (BMP)

4.3.4.1. Market size and forecast

4.3.5. Synthetic Bone Grafts

4.3.5.1. Market size and forecast

4.4.CELL BASED MATRICES (CBM)

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 WORLD BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

5.1 Overview

5.1.1 Market size and forecast

5.2 Spinal Fusion

5.2.1 Market size and forecast

5.3 Trauma

5.3.1 Market size and forecast

5.4 Craniomaxillofacial Surgery

5.4.1 Market size and forecast

5.5 Joint Reconstruction

5.5.1 Market size and forecast

5.6 Dental Bone Grafting

5.6.1 Market size and forecast

Chapter: 6 WORLD BONE GRAFT AND SUBSTITUTES MARKET, BY REGION

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S. market size and forecast
6.2.5 Canada market size and forecast
6.2.6 Mexicmarket size and forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany market size and forecast
6.3.5 France market size and forecast
6.3.6 U.K. market size and forecast
6.3.7 Italy market size and forecast
6.3.8 Spain market size and forecast
6.3.9 Rest of Europe market size and forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan market size and forecast
6.4.5 China market size and forecast
6.4.6 India market size and forecast
6.4.7 Australia market size and forecast
6.4.8 South Korea market size and forecast
6.4.9 Rest of Asia-Pacific market size and forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil market size and forecast
6.5.5 South Africa market size and forecast
6.5.6 Saudi Arabia market size and forecast
6.5.7 Israel market size and forecast
6.5.8 Rest of LAMEA market size and forecast

Chapter: 7 COMPANY PROFILES

7.1 Baxter International Inc.

7.1.1 Company Overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Business performance

7.2 Integra Lifesciences Holdings Corporation

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Business performance
7.2.5 Key strategic moves & developments

7.3 Stryker Corporation

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key strategic moves & developments

7.4 Zimmer Biomet Holdings, Inc.

7.4.1 Company Overview
7.4.2 Company Snapshot
7.4.3 Operating business segments
7.4.4 Business performance
7.4.5 Key Strategic Moves & Developments

7.5 Wright Medical Group N.V.

7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Business performance
7.5.5 Key strategic moves & developments

7.6 Xtant Medical Holdings, Inc.

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Business performance
7.6.5 Key strategic moves & developments

7.7 Johnson & Johnson

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Business performance
7.7.5 Key strategic moves & developments

7.8 Arthrex, Inc

7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Key strategic moves & developments

7.9 Musculoskeletal Transplant Foundation

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments

7.10 Medtronic plc

7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating Business Segments
7.10.4 Business Performance
7.10.5 Key Strategic Moves & Developments

Other players* in the value chain include:

  • NovaBone Products
  • LLC, BonAlive Biomaterials Ltd.
  • Sigma Graft Biomaterials
  • Pioneer Surgical Technology Inc.
  • RTI Biologics, Inc.
  • Orthofix International N.V.
  • Citagenix Inc.
  • Heraeus Medical GmbH
  • Graftys SA
  • NuVasive, Inc.

*Profiles of these players are not included. The same will be included on request.

List of Charts

FIG. 1 MARKET SEGMENTATION
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 4 MARKET SHARE ANALYSIS, BONE GRAFTS AND SUBSTITUTES, 2015
FIG. 5 MARKET SHARE ANALYSIS, MACHINED ALLOGRAFTS, 2015
FIG. 6 MARKET SHARE ANALYSIS, DEMINERALISED BONE MATRIX, 2015
FIG. 7 MARKET SHARE ANALYSIS, BONE MORPHOGENIC PROTEINS, 2015
FIG. 8 MARKET SHARE ANALYSIS, CELL BASED MATRICES, 2015
FIG. 9 MARKET SHARE ANALYSIS, SYNTHETIC BONE GRAFTS, 2015
FIG. 10 MARKET SHARE ANALYSIS, 2015
FIG. 11 MARKET DYNAMICS
FIG. 12 TOP IMPACTING FACTORS: WORLD BONE GRAFT AND SUBSTITUTES MARKET, 2014-2022
FIG. 13 WORLD BONE GRAFT AND SUBSTITUTES MARKET, BY TYPE
FIG. 14 U.S.: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 15 CANADA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 16 MEXICO: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 17 GERMANY: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 18 FRANCE: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 19 UK: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 20 ITALY: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 21 SPAIN: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 22 REST OF EUROPE: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 23 JAPAN: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 24 CHINA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 25 INDIA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 26 AUSTRALIA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 27 SOUTH KOREA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 28 REST OF ASIA-PACIFIC: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 29 BRAZIL: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 30 SOUTH AFRICA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 31 SAUDI ARABIA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 32 ISRAEL: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 33 REST OF LAMEA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), 2014-2022
FIG. 34 BAXTER: NET SALES ($MILLION), 20132015
FIG. 35 BAXTER: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIG. 36 BAXTER: NET SALES, BY GEOGRAPHY (%), 2015
FIG. 37 INTEGRA: NET SALES ($MILLION), 20132015
FIG. 38 INTEGRA: NET SALES, BY SEGMENT (%), 2015
FIG. 39 INTEGRA: NET SALES, BY GEOGRAPHY (%), 2015
FIG. 40 INTEGRA: STRATEGY SHARE (%), 2014-2016
FIG. 41 STRYKER: NET SALES ($MILLION), 20132015
FIG. 42 STRYKER: NET SALES, BY SEGMENT (%), 2015
FIG. 43 STRYKER: NET SALES, BY GEOGRAPHY (%), 2015
FIG. 44 STRYKER: STRATEGY SHARE (%), 20112015
FIG. 45 ZIMMER BIOMET: NET SALES ($MILLION), 20132015
FIG. 46 ZIMMER BIOMET: NET SALES, BY PRODUCT TYPE CATEGORY (%), 2015
FIG. 47 ZIMMER BIOMET: NET SALES, BY GEOGRAPHY (%), 2015
FIG. 48 ZIMMER BIOMET: STRATEGY SHARE (%), 2014-2016
FIG. 49 WRIGHT: NET SALES ($MILLION), 20132015
FIG. 50 WRIGHT: NET SALES, BY SEGMENT (%), 2015
FIG. 51 WRIGHT: NET SALES, BY GEOGRAPHY (%), 2015
FIG. 52 WRIGHT: STRATEGY SHARE (%), 20122015
FIG. 53 XTANT MEDICAL: NET SALES ($MILLION), 20132015
FIG. 54 XTANT MEDICAL: NET SALES, BY SEGMENT (%), 2015
FIG. 55 XTANT MEDICAL: NET SALES, BY GEOGRAPHY (%), 2015
FIG. 56 XTANT MEDICAL: STRATEGY SHARE (%), 2014-2016
FIG. 57 JOHNSON & JOHNSON: NET SALES ($MILLION), 20132015
FIG. 58 JOHNSON & JOHNSON: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIG. 59 JOHNSON & JOHNSON: NET SALES, BY GEOGRAPHY (%), 2015
FIG. 60 MEDTRONIC: NET SALES ($MILLION), 2014-2016
FIG. 61 MEDTRONIC: NET SALES, BY SEGMENT (%), 2016
FIG. 62 MEDTRONIC: NET SALES, BY GEOGRAPHY (%), 2016

List of Tables

TABLE 1 WORLD BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 2 ALLOGRAFT MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 3 DEMINERALIZED BONE MATRIX, BY REGION ($MILLION), 2014-2022
TABLE 4 MACHINED ALLOGRAFTS, BY REGION ($MILLION), 2014-2022
TABLE 5 BONE GRAFTS SUBSTITUTES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 6 BONE MORPHOGENETIC PROTEIN, BY REGION ($MILLION), 2014-2022
TABLE 7 SYNTHETIC BONE GRAFTS, BY REGION ($MILLION), 2014-2022
TABLE 8 CELL BASED MATRICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 9 WORLD BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 10 WORLD SPINAL FUSION MARKET, BY REGION ($MILLION), 2014-2022
TABLE 11 WORLD TRAUMA MARKET ($MILLION), BY REGION, 2014-2022
TABLE 12 WORLD CRANIOMAXILLOFACIAL MARKET ($MILLION) BY REGION, 2014-2022
TABLE 13 WORLD JOINT RECONSTRUCTION MARKET ($MILLION), BY REGION, 2014-2022
TABLE 14 WORLD DENTAL BONE GRAFTING MARKET ($MILLION), BY REGION, 2014-2022
TABLE 15 WORLD BONE GRAFT AND SUBSTITUTES MARKET ($MILLION), BY REGION, 2014-2022
TABLE 16 NORTH AMERICA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), BY COUNTRY, 2014-2022
TABLE 17 NORTH AMERICA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), BY TYPE, 2014-2022
TABLE 18 NORTH AMERICA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), BY APPLICATION, 2014-2022
TABLE 19 EUROPE: BONE GRAFTS AND SUBSTITUTES ($MILLION), BY COUNTRY, 2014-2022
TABLE 20 EUROPE: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), BY TYPE, 2014-2022
TABLE 21 EUROPE: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), BY APPLICATION, 2014-2022
TABLE 22 ASIA-PACIFIC: BONE GRAFTS AND SUBSTITUTES ($MILLION), BY COUNTRY, 2014-2022
TABLE 23 ASIA-PACIFIC: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), BY TYPE, 2014-2022
TABLE 24 ASIA-PACIFIC: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), BY APPLICATION, 2014-2022
TABLE 25 LAMEA: BONE GRAFTS AND SUBSTITUTES ($MILLION), BY COUNTRY, 2014-2022
TABLE 26 LAMEA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), BY TYPE, 2014-2022
TABLE 27 LAMEA: BONE GRAFTS AND SUBSTITUTES MARKET ($MILLION), BY APPLICATION, 2014-2022
TABLE 28 BAXTER: COMPANY SNAPSHOT
TABLE 29 BAXTER: OPERATING SEGMENTS
TABLE 30 INTEGRA: COMPANY SNAPSHOT
TABLE 31 INTEGRA: OPERATING SEGMENTS
TABLE 32 STRYKER: COMPANY SNAPSHOT
TABLE 33 STRYKER: OPERATING SEGMENTS
TABLE 34 ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 35 ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 36 WRIGHT: COMPANY SNAPSHOT
TABLE 37 WRIGHT: OPERATING SEGMENTS
TABLE 38 XTANT MEDICAL: COMPANY SNAPSHOT
TABLE 39 XTANT MEDICAL: OPERATING SEGMENTS
TABLE 40 JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 41 JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 42 ARTHREX: COMPANY SNAPSHOT
TABLE 43 ARTHREX: OPERATING SEGMENTS
TABLE 44 MTF: COMPANY SNAPSHOT
TABLE 45 MTF: OPERATING SEGMENTS
TABLE 46 MEDTRONIC: COMPANY SNAPSHOT
TABLE 47 MEDTRONIC: OPERATING SEGMENTS

 
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts